Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.63 USD | +0.77% | -4.36% | -10.85% |
Business Summary
Number of employees: 74
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Neuroscience and Immuno-oncology Drugs
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +268.00% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +268.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Vimal Mehta
FOU | Founder | 63 | 17-03-28 |
Director of Finance/CFO | 66 | 17-09-30 | |
Frank Yocca
CTO | Chief Tech/Sci/R&D Officer | 68 | 17-05-31 |
Vincent O'Neill
CTO | Chief Tech/Sci/R&D Officer | 55 | 17-06-30 |
Brennan Doyle
IRC | Investor Relations Contact | - | - |
Chetan Lathia
LAW | General Counsel | - | - |
Matthew Wiley
PRN | Corporate Officer/Principal | 52 | 22-01-18 |
Javier Rodriguez
LAW | General Counsel | 52 | 21-02-22 |
55 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 22-06-30 |
Peter Mueller
CHM | Chairman | 68 | 17-03-31 |
Sandeep Laumas
BRD | Director/Board Member | 56 | 17-08-31 |
Vimal Mehta
FOU | Founder | 63 | 17-03-28 |
55 | - | ||
Michal Votruba
BRD | Director/Board Member | 58 | 19-03-06 |
June Bray
BRD | Director/Board Member | 70 | 21-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 33,436,513 | 24,404,073 ( 72.99 %) | 0 | 72.99 % |
Company contact information
BioXcel Therapeutics, Inc.
555 Long Wharf Drive 12th floor
06511, New Haven
+475 238 6837
http://www.bioxceltherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.85% | 97.4M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- BTAI Stock
- Company BioXcel Therapeutics, Inc.